These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 36539347)

  • 21. Severe Pulmonary Hypertension: An Important Sequel After Severe Post-Acute COVID-19 Pneumonia.
    Cueto-Robledo G; Porres-Aguilar M; Puebla-Aldama D; Barragán-Martínez MDP; Jurado-Hernández MY; García-César M; Rojas MBT; García-Treminio C; Roldan-Valadez E
    Curr Probl Cardiol; 2022 Mar; 47(3):101004. PubMed ID: 34601005
    [No Abstract]   [Full Text] [Related]  

  • 22. Investigation and management of pulmonary embolism 1: a probability-based approach.
    Stolberg S; Mudawi D; Dean K; Cheng A; Barraclough R
    Br J Hosp Med (Lond); 2021 Jul; 82(7):1-16. PubMed ID: 34338014
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Radiologic evolution of pulmonary arterial thrombosis associated with SARS-CoV-2 pneumonia.
    Giacomazzi F; Mazzaccaro D; Schiaffino S; Giannetta M; Esseridou A; Cozzi A; Nano G; Righini P; Di Leo G; Serino G; Sardanelli F
    Vasa; 2022 Jul; 51(4):263-264. PubMed ID: 35786993
    [No Abstract]   [Full Text] [Related]  

  • 24. Comment on an article: "High dose folic acid is a potential treatment for pulmonary hypertension, including when associated with COVID-19 pneumonia".
    Ibrahimagić OĆ; Kunić S
    Med Hypotheses; 2020 Dec; 145():110338. PubMed ID: 33049593
    [No Abstract]   [Full Text] [Related]  

  • 25. Outcomes of COVID-19 infection in pediatric pulmonary hypertension: A single-center experience.
    Morales-Demori R; Mallory GB; Chartan C; Coleman R; Ruiz F; Villafranco N; Whalen E; Varghese N
    Pediatr Pulmonol; 2021 Dec; 56(12):3960-3965. PubMed ID: 34460150
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pulmonary arterial thrombosis as an important complication of COVID-19 pulmonary disease: letter to the editor.
    Lax SF; Skok K; Trauner M;
    Virchows Arch; 2020 Sep; 477(3):467-468. PubMed ID: 32772159
    [No Abstract]   [Full Text] [Related]  

  • 27. Inhaled milrinone for sick COVID-19 cohort: A pathophysiology driven hypothesis!
    Magoon R; ItiShri ; Kohli JK; Kashav R
    Med Hypotheses; 2021 Jan; 146():110441. PubMed ID: 33308938
    [No Abstract]   [Full Text] [Related]  

  • 28. Chronic thromboembolic pulmonary hypertension secondary to Behçet's disease: an extremely rare pediatric case.
    Mahdavi M; Asadian S; Rezaeian N; Asl Fallah S; Shahzadi H; Toloueitabar Y
    Cardiol Young; 2022 Feb; 32(2):315-319. PubMed ID: 34294181
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Integrated clinical role of echocardiography in patients with COVID-19 disease.
    Lazzeri C; Bonizzoli M; Peris A
    Heart; 2020 Dec; 106(23):1864. PubMed ID: 33055152
    [No Abstract]   [Full Text] [Related]  

  • 30. Identifying phenotypes of COVID-19, defining their pathogenesis, and targeting treatments could improve outcomes.
    Rajendram R; Kharal GA; Mahmood N; Kharal M
    Respir Physiol Neurobiol; 2020 Sep; 280():103477. PubMed ID: 32592752
    [No Abstract]   [Full Text] [Related]  

  • 31. Integrated clinical role of echocardiography in patients with COVID-19.
    Pagnesi M; Baldetti L; Beneduce A; Calvo F; Gramegna M; Pazzanese V; Ingallina G; Napolano A; Finazzi R; Ruggeri A; Ajello S; Melisurgo G; Camici PG; Scarpellini P; Tresoldi M; Landoni G; Ciceri F; Scandroglio AM; Agricola E; Cappelletti AM
    Heart; 2020 Dec; 106(23):1864-1865. PubMed ID: 33055151
    [No Abstract]   [Full Text] [Related]  

  • 32. SARS-CoV-2 Infection in Patients with Down Syndrome, Congenital Heart Disease, and Pulmonary Hypertension: Is Down Syndrome a Risk Factor?
    Krishnan US; Krishnan SS; Jain S; Chavolla-Calderon MB; Lewis M; Chung WK; Rosenzweig EB
    J Pediatr; 2020 Oct; 225():246-248. PubMed ID: 32610168
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [“Dum spiro spero”: clinicopathologic characteristics of SARS-CoV-2 infection].
    Zombori T; Kuthi L; Hortobágyi T; Csörgő E; Árgyelán J; Kocsis L; Sejben I; Kaizer L; Radics B; Sejben A; Pancsa T; Nyári GR; Baráth B; Cserni G; Iványi B; Tiszlavicz L
    Orv Hetil; 2021 Nov; 162(45):1791-1802. PubMed ID: 34747358
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Monoclonal antibody therapy in COVID-19.
    Conti P; Pregliasco FE; Calvisi V; Caraffa Al; Gallenga CE; Kritas SK; Ronconi G
    J Biol Regul Homeost Agents; 2021; 35(2):423-427. PubMed ID: 33904269
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Incidence and outcomes of COVID-19 in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: Data from the Hellenic pulmOnary hyPertension rEgistry (HOPE).
    Farmakis IT; Karyofyllis P; Frantzeskaki F; Demerouti E; Anthi A; Arvanitaki A; Pitsiou G; Naka KK; Bechlioulis A; Thomaidi A; Avgeropoulou A; Brili S; Mitrouska I; Manginas A; Orfanos SE; Tsangaris I; Giannakoulas G
    Hellenic J Cardiol; 2022; 64():93-96. PubMed ID: 34843997
    [No Abstract]   [Full Text] [Related]  

  • 36. Distribution of ACE2, CD147, CD26, and other SARS-CoV-2 associated molecules in tissues and immune cells in health and in asthma, COPD, obesity, hypertension, and COVID-19 risk factors.
    Radzikowska U; Ding M; Tan G; Zhakparov D; Peng Y; Wawrzyniak P; Wang M; Li S; Morita H; Altunbulakli C; Reiger M; Neumann AU; Lunjani N; Traidl-Hoffmann C; Nadeau KC; O'Mahony L; Akdis C; Sokolowska M
    Allergy; 2020 Nov; 75(11):2829-2845. PubMed ID: 32496587
    [TBL] [Abstract][Full Text] [Related]  

  • 37. COVID-19 patients may become predisposed to pulmonary arterial hypertension.
    Suzuki YJ; Nikolaienko SI; Shults NV; Gychka SG
    Med Hypotheses; 2021 Feb; 147():110483. PubMed ID: 33444904
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Unexpected Favourable Course of Coronavirus Disease 2019 in Chronic Thromboembolic Pulmonary Hypertension Patients.
    Segura de la Cal T; Nuche J; Jiménez López-Guarch C; Pérez-Olivares C; Velázquez M; López-Medrano F; López Gude MJ; Alonso Charterina S; Arribas Ynsaurriaga F; Escribano Subías P
    Arch Bronconeumol (Engl Ed); 2020 Nov; 56(11):749-752. PubMed ID: 32741643
    [No Abstract]   [Full Text] [Related]  

  • 39. Survival among people hospitalized with COVID-19 in Switzerland: a nationwide population-based analysis.
    Anderegg N; Panczak R; Egger M; Low N; Riou J
    BMC Med; 2022 Apr; 20(1):164. PubMed ID: 35468785
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dangerous liaisons? The role of inflammation and comorbidities in HIV and SARS-CoV-2 infection.
    Maggi P; Ricci E; Messina V; Salzillo A; Simeone F; Iodice A; Socio GV
    Expert Rev Clin Immunol; 2021 Mar; 17(3):201-208. PubMed ID: 33538189
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.